The sample was provided for investigation where the toxo igm results could be reproduced.The investigation determined the sample contains an interferent to the ruthenium component for both toxo igm and cmv igm.This particular patient sample is not suitable for elecsys toxo igm and cmv igm, due to the ruthenium label used in these assays.Per product labeling, "in rare cases, interference due to extremely high titers of antibodies to immunological components, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the elecsys toxo igm and cmv igm assays performed within specification.
|